Stay updated with breaking news from Cordis Accelerator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology
Ajax Health announced today that it formed and provided funding for Cortex, a new developer of ablation technology for treating AFib.
/PRNewswire/ -- Ajax Health announced today the formation and funding of Cortex, a medical technology company developing an integrated mapping and ablation...
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman Investment company hopes to create technology accelerator to speed bringing new innovations to market March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. Hellman & Friedman is a global private equity firm with investments in high-quality growth businesses. It is partnering in the transaction with Ajax Health and Zeus Health to build the Cordis business. Ajax identifies and supports scaling up di...
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman USA - English Share this article Share this article DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer's assumption of certain liabilities and seller's retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health's fiscal year 2022, subject to customary clos...